Evidence map›Paper›PMID 39926553›Full record

ArticleACS omega2025

Synthesis of Symmetrical Silane Containing P=O Bonds and Their Passivation of Perovskites.

Baoyang Dai, Shanshan Yan, Zhimi Chen, Tucai Zheng, Jie Qin, Junhua Zhao, Wanting Jin, Chunhui Zhou, Li Wan, Xing Su and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Baoyang DaiCollege of Chemical and Material Engineering, Quzhou University, Quzhou 324000, China.
Shanshan YanCollege of Chemical and Material Engineering, Quzhou University, Quzhou 324000, China.
Zhimi ChenCollege of Chemical and Material Engineering, Quzhou University, Quzhou 324000, China.
Tucai ZhengCollege of Chemical and Material Engineering, Quzhou University, Quzhou 324000, China.
Jie QinCollege of Chemical and Material Engineering, Quzhou University, Quzhou 324000, China.
Junhua ZhaoCollege of Chemical and Material Engineering, Quzhou University, Quzhou 324000, China.
Wanting JinCollege of Chemical and Material Engineering, Quzhou University, Quzhou 324000, China.
Chunhui ZhouCollege of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, China.ORCID https://orcid.org/0000-0001-5733-9011
Li WanDepartment of Chemical and Materials Engineering, The University of Auckland, Auckland 1010, New Zealand.
Xing SuCollege of Chemical and Material Engineering, Quzhou University, Quzhou 324000, China.
Chuanhua GaoCollege of Chemical and Material Engineering, Quzhou University, Quzhou 324000, China.ORCID https://orcid.org/0009-0003-0623-4473

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perovskite quantum dots (QDs) exhibit unique advantages, including a wide color gamut, narrow full width at half-maximum, cost-effectiveness, and high-efficiency luminescence, positioning them as a significant focus in contemporary optoelectronic research. Nevertheless, the synthesis of QDs often introduces crystal defects, while conventional in situ ligands can detrimentally affect the optoelectronic properties of perovskites. To overcome these challenges, we synthesized a symmetrical silane-based passivating agent containing phosphorus-oxygen double bonds. This agent enabled the in situ passivation of perovskites, significantly improving their optical performance and stability. Results showed that postpassivation QDs demonstrated bright green photoluminescence (PL) at 525 nm, with a 28% enhancement in PL intensity, a 16% increase in photoluminescence quantum yield, and an average lifetime (τ

Identifiers

PMID39926553
PMCPMC11799994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.